Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effect of Vicriviroc on HIV RNA Levels in Cerebrospinal Fluid.

Trial Profile

Effect of Vicriviroc on HIV RNA Levels in Cerebrospinal Fluid.

Phase of Trial: Phase I

Latest Information Update: 09 May 2014

At a glance

  • Drugs Vicriviroc (Primary)
  • Indications HIV-1 infections
  • Focus Therapeutic Use
  • Sponsors Schering-Plough
  • Most Recent Events

    • 16 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 22 Jul 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 22 Feb 2009 Additional location Puerto Rico, USA identified as reported by ClinicalTrials.gov, last updated 22 Feb 2009
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top